Cytosorbents
CTSO
#9825
Rank
HK$0.35 B
Marketcap
HK$5.68
Share price
-1.20%
Change (1 day)
-19.72%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2025 (TTM): -HK$88.7 Million

According to Cytosorbents's latest financial reports the company's current earnings are HK$36.1 Million. In 2024 the company made an earning of -HK$0.18 Billion, an increase over its 2023 earnings that were of -HK$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$88.7 Million-48.89%
2024 -HK$0.18 Billion-23.97%
2023 -HK$0.23 Billion-13.52%
2022 -HK$0.27 Billion34.04%
2021 -HK$0.2 Billion182.17%
2020 -HK$69.79 Million-55.97%
2019 -HK$0.16 Billion14.17%
2018 -HK$0.14 Billion95.14%
2017 -HK$71.14 Million-22.32%
2016 -HK$91.57 Million39.1%
2015 -HK$65.83 Million-12.89%
2014 -HK$75.57 Million89%
2013 -HK$39.99 Million26.65%
2012 -HK$31.57 Million-26.02%
2011 -HK$42.68 Million-288.45%
2010 HK$22.64 M-4.17%
2009 HK$23.63 M-287.19%
2008 -HK$12.63 Million-47.12%
2007 -HK$23.88 Million41.78%
2006 -HK$16.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Meridian Bioscience
VIVO
HK$0.43 B-585.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
HK$6.19 B-7,057.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
HK$25.45 B-28,683.67%๐Ÿ‡บ๐Ÿ‡ธ USA